<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2111200277
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Lamsev 800
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SEVELAMER CARBONATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        800
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        180
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        476.749
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Aurobindo Pharma Limited Unit VII" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Limited Unit VII
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 3103]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Aurobindo Pharma Saudi Arabia Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        V03AE02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Lamsev contains Sevelamer carbonate as the active substance. It binds phosphate from food in the digestive tract and so reduces serum phosphorus levels in the blood.</p><p>This medicine is used to control hyperphosphataemia (high blood phosphate levels) in:</p><p>&bull; Adult patients on dialysis (a blood clearance technique). It can be used in patients undergoing haemodialysis (using a blood filtration machine) or peritoneal dialysis (where fluid is pumped into the abdomen and an internal body membrane filters the blood);</p><p>&bull; Patients with chronic (long-term) kidney disease who are not on dialysis and have a serum (blood) phosphorus level equal to or above 1.78 mmol/l.</p><p>This medicine should be used with other treatments such as calcium supplements and vitamin D to prevent the development of bone disease.</p><p>Increased levels of serum phosphorus can lead to hard deposits in your body called calcification. These deposits can stiffen your blood vessels and make it harder for blood to be pumped around the body. Increased serum phosphorus can also lead to itchy skin, red eyes, bone pain and fractures.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Lamsev if:</p><p>&middot;&nbsp; &nbsp; You are allergic to the active substance or to any of the other ingredients of this medicine (listed in section 6).</p><p>&middot;&nbsp; &nbsp; &nbsp;you have low levels of phosphate in your blood (your doctor will check this for you)</p><p>&middot;&nbsp; &nbsp; &nbsp;you have bowel obstruction</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor before taking Lamsev if any of the following applies to you:</p><p>&middot;&nbsp; &nbsp; Swallowing problems. Your doctor can rather prescribe Lamsev powder for oral suspension</p><p>&middot;&nbsp; &nbsp; problems with motility (movement) in your stomach and bowel</p><p>&middot;&nbsp;&nbsp; being sick frequently</p><p>&middot;&nbsp;&nbsp;&nbsp;active inflammation of the bowel</p><p>&middot;&nbsp; &nbsp;have undergone major surgery on your stomach or bowel.</p><p>Talk to your doctor while taking Lamsev :</p><p>&middot;&nbsp; &nbsp;if you experience severe abdominal pain, stomach or intestine disorders, or blood in the stool (gastrointestinal bleeding). These symptoms can be due to Sevelamer crystals deposit in your bowel. Contact your doctor who will decide on continuing the treatment or not.</p><p><em>Additional treatments</em></p><p>Due to either your kidney condition or your dialysis treatment you may:</p><p>&middot;&nbsp; develop low or high levels of calcium in your blood. Since this medicine does not contain calcium your doctor might prescribe additional calcium tablets.</p><p>&middot;&nbsp; &nbsp;have a low amount of vitamin D in your blood. Therefore, your doctor may monitor the levels of vitamin D in your blood and prescribe additional vitamin D as necessary. If you do not take multivitamin supplements you may also develop low levels of vitamins A, E, K and folic acid in your blood and therefore your doctor may monitor these levels and prescribe supplemental vitamins as necessary.</p><p>&middot;&nbsp; &nbsp;have disturbed level of bicarbonate in your blood and increased acidity in the blood and other body tissue. Your doctor should monitor the level of bicarbonate in your blood.</p><p><em>Special note for patients on peritoneal dialysis</em></p><p>You may develop peritonitis (infection of your abdominal fluid) associated with your peritoneal dialysis. This risk can be reduced by careful adherence to sterile techniques during bag changes. You should tell your doctor immediately if you experience any new signs or symptoms of abdominal distress, abdominal swelling, abdominal pain, abdominal tenderness, or abdominal rigidity, constipation, fever, chills, nausea or vomiting.</p><p><strong>Children</strong></p><p>The safety and efficacy in children (below the age of 6 years) have not been studied. Therefore this medicine is not recommended for use in children below the age of 6 years.</p><p><strong>Other medicines and Lamsev </strong></p><p>Tell your doctor if you are taking, have recently taken or might take any other medicines.</p><p>&middot;&nbsp;&nbsp;Lamsev should not be taken at the same time as ciprofloxacin (an antibiotic).</p><p>&middot;&nbsp;&nbsp;If you are taking medicines for heart rhythm problems or for epilepsy, you should consult your doctor when taking.</p><p>&middot;&nbsp; The effects of medicines such as ciclosporin, mycophenolate mofetil and tacrolimus (medicines used to suppress the immune system) may be reduced by Lamsev . Your doctor will advise you if you are taking these medicines.</p><p>&middot;&nbsp; Thyroid hormone deficiency may uncommonly be observed in certain people taking levothyroxine (used to treat low thyroid hormone levels) and Lamsev . Therefore your doctor may monitor the levels of thyroid stimulating hormone in your blood more closely.</p><p>&middot;&nbsp; Medicines treating heartburn and reflux from your stomach or oesophagus, such as omeprazole, pantoprazole, or lansoprazole, known as &ldquo;proton pump inhibitors&rdquo;, may reduce the efficacy of Lamsev . Your doctor may monitor the phosphate level in your blood.</p><p>Your doctor will check for interactions between Lamsev and other medicines on a regular basis.</p><p>In some cases where LAMSEV should be taken at the same time as another medicine, your doctor may advise you to take this medicine 1 hour before or 3 hours after Lamsev intake. Your doctor may also consider monitoring the levels of that medicine in your blood.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>The potential risk of Lamsev during human pregnancy is unknown. Talk to your doctor who will decide if you can continue the treatment with Lamsev .</p><p>It is unknown whether Lamsev is excreted in breast milk and may affect your baby. Talk to your doctor who will decide if you can breastfeed your baby or not, and if it is necessary to stop treatment.</p><p><strong>Driving and using machines</strong></p><p>Lamsev is unlikely to affect your ability to drive or to use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You must take Lamsev as prescribed by your doctor. They will base the dose on your serum phosphorus level.</p><p>The recommended starting dose of LAMSEV tablets for adults and elderly is one to two tablets of 800 mg with each meal, 3 times a day. Check with your doctor, pharmacist or nurse if you are not sure.</p><p>Take Lamsev after your meal or with food</p><p>The tablets must be swallowed whole. Do not crush, chew or break into pieces.</p><p>Initially, your doctor will check the levels of phosphorus in your blood every 2-4 weeks and may adjust the dose of Lamsev when necessary to reach an adequate phosphate level.</p><p>Follow the diet prescribed by your doctor.</p><p><strong>If you take more Lamsev </strong><strong>than you should</strong></p><p>In the event of a possible overdose you should contact your doctor immediately.</p><p><strong>If you forget to take Lamsev </strong></p><p>If you have missed one dose, this dose should be omitted and the next dose should be taken at the usual time with a meal. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Lamsev </strong></p><p>Taking your Lamsev treatment is important to maintain an appropriate phosphate level in your blood. Stopping Lamsev would lead to important consequences such as calcification in the blood vessels. If you consider stopping your Lamsev treatment, contact your doctor or pharmacist first.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Constipation is a very common side effect (may affect more than 1 in 10 people). It can be an early symptom of a blockage in your intestine. In case of constipation, please inform your doctor or pharmacist.</p><p>Some side effects could be serious. If you get any of the following side effects, seek immediate medical attention:</p><p>&middot;&nbsp; &nbsp;Allergic reaction (signs including rash, hives, swelling, trouble breathing). This is a very rare side effect (may affect up to 1 in 10,000 people).</p><p>&middot;&nbsp; &nbsp;Blockage in the intestine (signs include: severe bloating; abdominal pain, swelling or cramps; severe constipation) has been reported. Frequency is not known (frequency cannot be estimated from the available data).</p><p>&middot;&nbsp; &nbsp;Rupture in the intestinal wall (signs include: severe stomach pain, chills, fever, nausea, vomiting, or a tender abdomen) has been reported. Frequency is not known.</p><p>Other side effects have been reported in patients taking Lamsev :</p><p><strong><em>Very common: </em></strong></p><p>Vomiting, upper abdominal pain, nausea</p><p><strong><em>Common (may affect up to 1 in 10 people): </em></strong></p><p>Diarrhoea, stomach ache, indigestion, flatulence</p><p><strong><em>Not known:</em></strong></p><p>Cases of itching, rash, slow intestine motility (movement)</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use this medicine after the expiry date stated on the bottle after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Store below 30<sup>o</sup>C.</p><p>Keep the bottle container tightly closed in order to protect from moisture.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is Sevelamer carbonate.</p><p>Each film-coated tablet contains 800 mg of Sevelamer carbonate</p><p>The other ingredients are Mannitol, Crospovidone, Hydroxypropyl Cellulose, Colloidal silicon dioxide, Talc, Glyceryl Behenate, Aquarius Prime BBN119000 clear and Opacode Black S-1-17823.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lamsev film-coated tablets are White to off white, oval shaped, film-coated tablets, imprinted with “J 75” on one side with Edible Black ink and plain on other side. 
The tablets are packed in high density polyethylene bottles with a polypropylene cap and an induction seal.
Lamsev is available in HDPE pack of 180’s.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer:</strong></p><p><strong>AUROBINDO PHARMA LTD.,</strong></p><p>Unit VII, SEZ, TSIIC, Plot No. SI,</p><p>Survey No&rsquo;s: 411/P, 425/P, 434/P, 435/P &amp; 458/P,</p><p>Green Industrial Park, Polepally village,</p><p>Jedcherla Mandal, Mahaboobnagar District,</p><p>Telangana, India.</p><p><strong>Marketing Authorization Holder:</strong></p><p>Aurobindo Pharma Saudi Arabia Limited</p><p>Jeddah, Saudi Arabia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي لامسيف على كربونات السيفيلامير كمادة فعالة، ويتحد مع الفوسفات الناجم عن الطعام في القناة الهضمية مؤديًا إلى خفض مستويات الفوسفات المصلية في الدم.</p><p dir="RTL">يُستخدم هذا الدواء للتحكم في فرط فوسفات الدم (ارتفاع مستويات الفوسفات في الدم) لدي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المرضى البالغين الخاضعين للديال (تقنية لتصفية الدم). ويُمكن استخدامه مع المرضى الذين يُجرون غسيلًا كلويًا (باستخدام آلة لترشيح الدم)، أو ديالًا صفاقيًا (وفيه يُضخ السائل للبطن ويُرشح الدم بواسطة أغشية الجسم الداخلية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المرضى الذين يعانون من أمراض كلوية مزمنة (طويلة المدى) غير الخاضعين للديال، وأصبحت مستويات الفوسفور المصلي (بالدم) لديهم مساوية لـ 1.78 ميللي مول/لتر أو أعلى.</p><p dir="RTL">يجب استعمال هذا الدواء مع أدوية أخرى مثل مكملات الكالسيوم وفيتامين D لمنع حدوث أمراض العظام.</p><p dir="RTL">قد تؤدي مستويات الفوسفور الزائدة إلى ترسبات صلبة في جسمك تُسمى التكلسات. قد تعمل هذه الترسبات على تصلب الأوعية الدموية، والذي يؤدي إلى صعوبة ضخ الدم لأنحاء الجسم. وقد تؤدي زيادة الفوسفور المصلي أيضًا إلى حكة الجلد واحمرار العينين وآلام العظام وكسورها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تأخذ لامسيف:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك حساسية تجاه المادة الفعالة لهذا الدواء أو أي من مكوناته الأخرى (مذكورة في قسم 6).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن كانت مستويات الفوسفات بدمك منخفضة (سيتحقق الطبيب من ذلك)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن كنت مصابًا بانسداد معوي</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">تحدث مع طبيبك قبل أخذ لامسيف إن انطبق أي من التالي عليك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل بالبلع. قد يصف الطبيب حينئذ مسحوق لامسيف للمُعلق الفموي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل بحركة المعدة والأمعاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور متكرر بالإعياء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب نشط بالأمعاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن أجريت جراحة رئيسية بالمعدة أو الأمعاء</p><p dir="RTL">تحدث مع طبيبك أثناء أخذ لامسيف:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;إن عانيت من ألم شديد بالبطن أو اضطرابات بالمعدة أو الأمعاء أو دماء بالبراز (نزف بالقناة الهضمية). قد تعود تلك الأعراض لترسب بلورات سيفيلامير في الأمعاء. تواصل مع طبيبك الذي سيقرر إن كنت ستُكمل العلاج أم لا.</p><p dir="RTL"><em>&nbsp;العلاجات الإضافية</em></p><p dir="RTL">نتيجة لحالة كليتيك أو العلاج الديالي الخاص بك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يزداد مستوى الكالسيوم أو ينقص بدمك. ونظرًا لعدم احتواء هذا الدواء على الكالسيوم، قد يصف الطبيب أقراص كالسيوم إضافية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تنقص كمية فيتامين D بدمك. وبالتالي، قد يرصد طبيبك مستويات فيتامين D بدمك، ويصف فيتامين D إضافي عند الحاجة. إن لم تكن تأخذ مكملات عديدة الفيتامينات، قد تنقص أيضًا مستويات فيتامينات A وE وK وحامض الفوليك بدمك، وبالتالي قد يرصد طبيبك تلك المستويات ويصف فيتامينات مُكملة عند الحاجة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تضطرب مستويات البيكربونات في دمك، وتزداد الحموضة بدمك وأنسجة الجسم الأخرى. يجب أن يرصد الطبيب مستوى البيكربونات بدمك.</p><p dir="RTL"><em>نصائح خاصة للمرضى الخاضعين للديال الصفاقي</em></p><p dir="RTL">قد يحدث التهاب بالصفاق (عدوى بسائل البطن) ترتبط بالديال الصفاقي. ويُمكن خفض هذا الخطر بالالتزام بالتقنيات المعقمة أثناء تغيير الأكياس. يجب أن تُعلم الطبيب على الفور إن عانيت من أي علامات أو أعراض جديدة لتوتر البطن أو تورم البطن أو ألم البطن أو ليونة البطن أو تصلب البطن أو الإمساك أو الحمى أو الارتعاش أو الغثيان أو القيء.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لم تُدرس المأمونية والفعالية لدي الأطفال (الأقل من 6 أعوام). وبالتالي لا يوصى باستعمال هذا الدواء مع الأطفال الأقل من 6 أعوام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى ولامسيف</strong></p><p dir="RTL">أعلم طبيبك إن كنت تأخذ أو أخذت حديثًا أو قد تأخذ أي دواء آخر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يجب أخذ لامسيف في نفس الوقت مع سيبروفلوكساسين (مضاد حيوي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن كنت تأخذ أدوية لمشاكل نظم القلب أو الصرع، يجب عليك حينئذ استشارة الطبيب عند الأخذ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يُخفض لامسيف من آثار أدوية مثل سيكلوسبورين وميكوفينولات موفيتيل وتاكروليموس (أدوية تُستخدم لتثبيط الجهاز المناعي). سينصحك طبيبك إن كنت تأخذ هذه الأدوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يُلاحظ نقص الهرمون الدرقي لدي بعض الأشخاص الذين يأخذون ليفوثيروكسين (يُستخدم لعلاج انخفاض مستويات الهرمون الدرقي) ولامسيف. وبالتالي، قد يرصد طبيبك مستويات الهرمون المُحفز للدرق في دمك عن كثب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد ينخفض تأثير لامسيف بسبب أدوية علاج حرقة المعدة والارتجاع من المعدة أو الأمعاء، مثل أوميبرازول أو بانتوبرازول أو لانسوبرازول، والتي تُعرف باسم &quot;مثبطات المضخات البروتونية&quot;. قد يرصد الطبيب مستوى الفوسفات بدمك.</p><p dir="RTL">سيتحقق الطبيب من تفاعل لامسيف مع الأدوية الأخرى بشكل متكرر.</p><p dir="RTL">في بعض الأحيان التي يجب فيها أخذ لامسيف مع دواء آخر في نفس الوقت، قد ينصحك طبيبك بأخذ هذا الدواء قبل أخذ لامسيف بساعة أو بعده بثلاث ساعات. وقد ينظر الطبيب أيضًا في رصد مستويات هذا الدواء بدمك.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنت حاملًا أو ترضعين رضاعة طبيعية، أو تعتقدين أنك ربما تكونين حاملاً أو تخططين للحمل، فاطلبي نصيحة طبيبك قبل تناول هذا الدواء.</p><p dir="RTL">الخطورة المحتملة للامسيف أثناء الحمل البشري غير معلومة. تحدثي مع طبيبك الذي سيقرر إمكانية استمرار العلاج بلامسيف.</p><p dir="RTL">من غير المعلوم إن كان لامسيف يُفرز في حليب الثدي وبالتالي قد يؤثر على الجنين أم لا. تحدثي مع طبيبك الذي سيقرر إمكانية إرضاعك لطفلك أم لا، وإن كان من اللازم إيقاف العلاج.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">من غير المتوقع أن يؤثر لامسيف على قدرتك على القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب أن تأخذ لامسيف كما يصف طبيبك، حيث سيحدد الجرعة بناءً على مستوى الفوسفور المصلي.</p><p dir="RTL">الجرعة المبدئية الموصي بها من أقراص لامسيف للبالغين والمسنين هي قرص واحد إلى قرصين 800 مجم مع كل وجبة 3 مرات يوميًا. تحقق من طبيبك أو الصيدلي أو الممرضة إن لم تكن متأكدًا.</p><p dir="RTL">خد لامسيف بعد وجبتك أو مع الطعام</p><p dir="RTL">يجب ابتلاع الأقراص كاملة. لا تطحنها أو تمضغها أو تكسرها لأجزاء صغيرة.</p><p dir="RTL">مبدئيًا، سيتحقق طبيبك من مستويات الفوسفور بدمك كل 2-4 أسبوع، وقد يُعدل جرعة لامسيف عند الحاجة للوصول لمستوى الفوسفات الصحيح.</p><p dir="RTL">اتبع النظام الغذائي الذي يصفه طبيبك.</p><p dir="RTL"><strong>إذا أخذت أكثر مما يجب من لامسيف</strong></p><p dir="RTL">في حالة الجرعة المفرطة، يجب أن تتواصل مع الطبيب على الفور.</p><p dir="RTL"><strong>إذا نسيت تناول لامسيف</strong></p><p dir="RTL">إن نسيت أخذ جرعة، يجب تجاهل تلك الجرعة حينئذ، وأخذ الجرعة التالية في موعدها المعتاد مع الطعام. لا تأخذ جرعة مزدوجة للتعويض عن الجرعة المنسية.</p><p dir="RTL"><strong>إذا توقفت عن أخذ لامسيف</strong></p><p dir="RTL">من المهم أخذ لامسيف للحفاظ على مستوى الفوسفات الصحيح بدمك. سيؤدي التوقف عن أخذ لامسيف إلى عواقب هامة مثل حدوث تكلسات بالأوعية الدموية. إن كنت تفكر في إيقاف العلاج بلامسيف، تواصل مع الطبيب أو الصيدلي أولًا.</p><p dir="RTL">اسأل طبيبك أو الصيدلي إن كانت لديك أي أسئلة إضافية حول استخدام هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يتسبب هذا الدواء بآثار جانبية، بالرغم من عدم إصابة الجميع بها.</p><p dir="RTL">الإمساك أثر جانبي شائع جدًا (قد يصيب أكثر من 1 لكل 10 أشخاص). وقد يكون عرض مُبكر لانسداد الأمعاء. في حالة حدوث إمساك، يُرجى إعلام الطبيب أو الصيدلي.</p><p dir="RTL"><strong>بعض الآثار الجانبية قد تكون خطيرة. إن عانيت أي من الآثار الجانبية التالية، اطلب الرعاية الطبية العاجلة:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات تحسسية (تتضمن العلامات كل من الطفح والشرى والتورم وصعوبة التنفس). هذا أثر جانبي شديد الندرة (قد يُصيب 1 لكل 10000 شخص).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أُبلغ عن حدوث انسداد الأمعاء (تتضمن العلامات كل من الانتفاخ وآلام البطن والتورم أو التقلصات والإمساك الشديد). التكرارية غير معلومة (لا يمكن تحديد التكرارية من البيانات المتاحة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أُبلغ عن حدوث تمزق الجدار المعوي (تتضمن العلامات كل من ألم المعدة الشديد أو الارتعاش أو الحمى أو الغثيان أو القيء أو ليونة البطن). التكرارية غير معلومة.</p><p dir="RTL"><strong>الآثار الجانبية الأخرى التي أُبلغ عنها لدي المرضى الذين يأخذون لامسيف:</strong></p><p dir="RTL"><strong><em>شائعة جدًا:</em></strong></p><p dir="RTL">&nbsp;قيء، ألم بأعلى البطن، غثيان</p><p dir="RTL"><strong><em>شائعة (قد تُصيب 1 لكل 10 أشخاص):</em></strong></p><p dir="RTL">&nbsp;إسهال، ألم بالمعدة، عسر هضم، انتفاخ</p><p dir="RTL"><strong><em>غير معلومة:</em></strong></p><p dir="RTL">حالات حكة، طفح، بطء حركة الأمعاء</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا أصبت بأي آثار جانبية، تواصل مع طبيبك أو الصيدلي. ويتضمن ذلك أية آثار جانبية محتملة غير مدرجة بهذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ بعيدًا عن نظر الأطفال ومتناول أيديهم.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ الانتهاء المذكور على الزجاجة بعد &ldquo;EXP&rdquo;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">يخزن في درجة حرارة أقل من 30 درجة مئوية،</p><p dir="RTL">احتفظ بالعبوة الزجاجية مُحكمة الغلق لحماية الدواء من الرطوبة.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق الصرف الصحي أو النفايات المنزلية. واسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي كربونات السيفيلامير.</p><p dir="RTL">يحتوي كل قرص مغلف على 800 مجم من كربونات السيفيلامير</p><p dir="RTL">&nbsp;المكونات الأخرى هي مانيتول وكروسبوفيدون وهيدروكسي بروبيل سيليولوز وثاني أكسيد السيليكون الغروي وتلك جليسريل بيهينات وأكواريوس برايم BBN119000 شفاف وأوباكود أسود S-1-17823.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص لامسيف المغلفة عبارة عن أقراص مغلفة بيضاوية لونها أبيض إلى أبيض داكن، ومحفور على أحد جانبيها &quot;J 75&quot; بحبر أسود صالح للأكل، بينما الجانب الآخر خالِ تمامًا. الأقراص مُغلفة في زجاجات من البولي إيثيلين عالِ الكثافة، ومزودة بغطاء من البولي بروبيلين وسدادة مُحكمة.</p><p dir="RTL">يتوفر لامسيف في عبوة من البولي إيثيلين عالِ الكثافة تحتوي على 180 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المُصنعة :</strong></p><p dir="RTL"><strong>أوروبيندو فارما المحدودة،</strong></p><p dir="RTL">الوحدة VII، المنطقة الاقتصادية الخاصة، شركة البنية التحتية الصناعية بولاية تيلانجانا، قطعة رقم S1،</p><p dir="RTL">مسح رقم: &rlm;411/P، 425/P، 434/P، 435/P، 458/P،</p><p dir="RTL">الحديقة الصناعية الخضراء، قرية بوليبالي،</p><p dir="RTL">منطقة جيدشيرلا، حي ماهابوبناجار،</p><p dir="RTL">تيلانجانا، الهند.</p><p dir="RTL"><strong>حامل ترخيص التسويق:</strong></p><p dir="RTL">أوروبيندو فارما السعودية المحدودة،</p><p dir="RTL">جدة، المملكة العربية السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lamsev 800
(Sevelamer Carbonate Tablets mg)

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sevelamer Carbonate Tablets 800 mg:
Each film-coated tablet contains: 800 mg of Sevelamer carbonate
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sevelamer Carbonate Tablets 800 mg:
White to off white, oval shaped, film-coated tablets, imprinted with “J 75” on one side with Edible Black ink and plain on other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sevelamer Carbonate is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.</p><p>Sevelamer Carbonate is also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD) not on dialysis with serum phosphorus &gt; 1.78 mmol/l.</p><p>Sevelamer carbonate should be used within the context of a multiple therapeutic approach, which&nbsp;could&nbsp;include&nbsp;calcium&nbsp;supplement,&nbsp;1, 25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Starting Dose</u></em></strong></p><p>The recommended starting dose of Sevelamer carbonate is 2.4 g or 4.8 g per day based on</p><p>clinical needs and serum phosphorus level. Sevelamer Carbonate must be taken three times per day with meals.</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Serum phosphorus level in patients</p></td><td style="vertical-align:top"><p>Total daily dose of Sevelamer carbonate to be taken over 3 meals per day</p></td></tr><tr><td style="vertical-align:top"><p>1.78 &ndash; 2.42 mmol/l (5.5 &ndash; 7.5 mg/dl)</p></td><td style="vertical-align:top"><p>2.4 g*</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 2.42 mmol/l (&gt; 7.5 mg/dl)</p></td><td style="vertical-align:top"><p>4.8 g*</p></td></tr></tbody></table><p>*Plus subsequent titrating, see section &ldquo;Titration and maintenance&rdquo;</p><p>For patients previously on phosphate binders (Sevelamer hydrochloride or calcium based), Sevelamer Carbonate should be given on a gram for gram basis with monitoring of serum phosphorus levels to ensure optimal daily doses.</p><p><strong><u>Titration</u><u> and Maintenance</u></strong></p><p>Serum phosphorus levels must be monitored and the dose of Sevelamer carbonate titrated by 0.8 g three times per day (2.4 g/day) increments every 2-4 weeks until an acceptable serum phosphorus level is reached, with regular monitoring thereafter.</p><p>Patients taking Sevelamer carbonate should adhere to their prescribed diets.</p><p>In clinical practice, treatment will be continuous based on the need to control serum phosphorus levels and the daily dose is expected to be an average of approximately 6 g per day.</p><p><strong><u>Paediatric population</u></strong></p><p>The safety and efficacy of Sevelamer Carbonate have not been established in children below the age of 6 years or in children with a BSA below 0.75 m2.</p><p><u>For</u><u> </u><u>Paediatric</u><u> </u><u>patients</u><u> </u><u>the oral suspension should be administered, as tablet formulations are</u> <u>not appropriate for this population</u>.</p><p><strong><u>Method</u><u> of administration</u></strong></p><p>Oral use.</p><p>Tablets should be swallowed intact and should not be crushed, chewed, or broken into pieces prior to administration.</p><p>Sevelamer Carbonate should be taken with food and not on an empty stomach.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
•	Hypophosphataemia
•	Bowel obstruction.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety and efficacy of Sevelamer carbonate have not been established in adult patients with chronic kidney disease not on dialysis with serum phosphorus &lt; 1.78 mmol/l. Therefore it is currently not recommended for use in these patients.</p><p>The safety and efficacy of Sevelamer carbonate have not been established in patients with the following disorders:</p><p>&bull;&nbsp; Dysphagia</p><p>&bull;&nbsp; Swallowing disorders</p><p>&bull;&nbsp;&nbsp; Severe &nbsp;gastrointestinal &nbsp;motility&nbsp; disorders &nbsp;including &nbsp;untreated &nbsp;or &nbsp;severe &nbsp;gastroparesis, retention of gastric contents and abnormal or irregular bowel motion</p><p>&bull;&nbsp; Active inflammatory bowel disease</p><p>&bull;&nbsp; Major gastrointestinal tract surgery</p><p>Therefore caution should be exercised when it is used in these patients.</p><p><strong><u>Intestinal obstruction and ileus/sub ileus</u></strong></p><p>In very rare cases, intestinal obstruction and ileus/sub ileus have been observed in patients during treatment with Sevelamer hydrochloride (capsules/tablets), which contains the same active moiety as Sevelamer carbonate. Constipation may be a preceding symptom. Patients who are constipated should be monitored carefully while being treated with Sevelamer Carbonate. The treatment should be re-evaluated in patients who develop severe constipation or other severe</p><p>Gastrointestinal symptoms.</p><p><strong><u>Fat-soluble vitamins</u></strong></p><p>Patients with CKD may develop low levels of fat-soluble vitamins A, D, E and K, depending on dietary intake and the severity of their disease. It cannot be excluded that Sevelamer carbonate can bind fat-soluble vitamins contained in ingested food. In patients not taking supplemental vitamins but on Sevelamer, serum vitamin A, D, E and K status should be assessed regularly. It is recommended that vitamin supplements be given if necessary. It is recommended that CKD patients not on dialysis are given vitamin D supplements (approximately 400 IU of native vitamin D daily) which can be part of a multivitamin preparation to be taken apart from their dose of Sevelamer carbonate. In patients undergoing peritoneal dialysis additional monitoring of fat-soluble vitamins and folic acid is recommended, since vitamin A, D, E and K levels were not measured in a clinical study in these patients.</p><p><strong><u>Folate </u><u>deficiency</u></strong></p><p>There is at present insufficient data to exclude the possibility of folate deficiency during long term Sevelamer carbonate treatment.</p><p><strong><u>Hypocalcaemia/hypercalcaemia</u></strong></p><p>Patients with CKD may develop hypocalcaemia or hypercalcaemia. Sevelamer carbonate does not contain any calcium. Serum calcium levels should therefore be monitored at regular intervals and elemental calcium should be given as a supplement if required.</p><p><strong><u>Metabolic acidosis</u></strong></p><p>Patients with CKD are predisposed to developing metabolic acidosis. As part of good clinical practice, monitoring of serum bicarbonate levels is therefore recommended.</p><p><strong><u>Peritonitis</u></strong></p><p>Patients receiving dialysis are subject to certain risks for infection specific to dialysis modality. Peritonitis is a known complication in patients receiving peritoneal dialysis and in a clinical trial with Sevelamer hydrochloride, a greater number of peritonitis cases were reported in the Sevelamer group than in the control group. Patients on peritoneal dialysis should be closely monitored to ensure the correct use of appropriate aseptic technique with the prompt recognition and management of any signs and symptoms associated with peritonitis.</p><p><strong><u>Swallowing</u><u> </u><u>and</u><u> </u><u>choking</u><u> difficulties</u></strong></p><p>Uncommon reports of difficulty swallowing the Lamsiv tablet have been reported. Many of these cases involved patients with co-morbid conditions including swallowing disorders or oesophageal abnormalities. Caution should be exercised when it is used in patients with difficulty swallowing. The use of Sevelamer carbonate powder in patients with a history of difficulty swallowing should be considered.</p><p><strong><u>Hypothyroidism</u></strong></p><p>Closer monitoring of patients with hypothyroidism co-administered with Sevelamer carbonate and levothyroxine is recommended (see section 4.5).</p><p><strong><u>Long-term</u><u> chronic treatment</u></strong></p><p>In a clinical trial of one year, no evidence of accumulation of Sevelamer was seen. However the potential absorption and accumulation of Sevelamer during long-term chronic treatment (&gt; one year) cannot be totally excluded (see section 5.2).</p><p><strong><u>Hyperparathyroidism</u></strong></p><p>Sevelamer carbonate is not indicated for the control of hyperparathyroidism. In patients with secondary hyperparathyroidism Sevelamer carbonate should be used within the context of a multiple therapeutic approach, which could include calcium as supplements, 1,25-dihydroxy Vitamin&nbsp;D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels. &nbsp;</p><p><strong><u>Inflammatory Gastrointestinal Disorders</u></strong></p><p>Cases of serious inflammatory disorders of different parts of the gastrointestinal tract (including serious complications such as bleeding, perforation, ulceration, necrosis, colitis) associated with the presence of Sevelamer crystals have been reported in literature. However, the causality of the Sevelamer crystals in initiating such disorders has not been demonstrated. Sevelamer carbonate treatment should be re-evaluated in patients who develop severe gastrointestinal symptoms.</p><p><strong><u>Excipients</u></strong></p><p>This medicine contains less than 1 mmol sodium (23 mg) per 800 mg that is to say essentially &#39;sodium-free&#39;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Dialysis</u></p><p>Interaction studies have not been conducted in patients on dialysis.</p><p><u>Ciprofloxacin</u></p><p>In interaction studies in healthy volunteers, Sevelamer hydrochloride, which contains the same active moiety as Sevelamer carbonate, decreased the bioavailability of ciprofloxacin by approximately 50% when co-administered with Sevelamer hydrochloride in a single dose study. Consequently, Sevelamer carbonate should not be taken simultaneously with ciprofloxacin.</p><p><u>Ciclosporin,</u><u> mycophenolate mofetil and tacrolimus in transplant patients</u></p><p>Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when coadministered with Sevelamer hydrochloride without any clinical consequences (e.g., graft rejection). The possibility of an interaction cannot be excluded and a close monitoring of blood concentrations of ciclosporin, mycophenolate mofetil and tacrolimus should be considered during the use of combination and after its withdrawal.</p><p><u>Levothyroxine</u></p><p>Very rare cases of hypothyroidism have been reported in patients co-administered with Sevelamer hydrochloride, which contains the same active moiety as Sevelamer carbonate, and levothyroxine. Closer monitoring of thyroid stimulating hormone (TSH) levels is therefore recommended in patients receiving Sevelamer carbonate&nbsp;&nbsp; &nbsp;and levothyroxine.</p><p><u>Anti-arrhythmics</u><u> </u><u>and</u><u> </u><u>anti-seizure medicinal</u><u> </u><u>products</u></p><p>Patients taking anti-arrhythmic medicinal products for the control of arrhythmias and anti-seizure medicinal products for the control of seizure disorders were excluded from clinical trials. Caution should be exercised when prescribing Sevelamer carbonate to patients also taking these medicinal products.</p><p><u>Digoxin,</u><u> warfarin, enalapril or metoprolol</u></p><p>In interaction studies in healthy volunteers, Sevelamer hydrochloride, which contains the same active moiety as Sevelamer carbonate, had no effect on the bioavailability of digoxin, warfarin, enalapril or metoprolol.</p><p><u>Proton</u><u> pump inhibitors</u></p><p>During post-marketing experience, very rare cases of increased phosphate levels have been reported in patients taking proton pump inhibitors co-administered with Sevelamer carbonate.</p><p><u>Bioavailability</u></p><p>Sevelamer carbonate is not absorbed and may affect the bioavailability of other medicinal products. When administering any medicinal product where a reduction in the bioavailability could have a clinically significant effect on safety or efficacy, the medicinal product should be administered at least one hour before or three hours after Sevelamer carbonate, or the physician should consider monitoring blood levels.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There are no or limited amount of data from the use of Sevelamer in pregnant women. Animal studies have shown some reproductive toxicity when Sevelamer was administered to rats at high doses (see section 5.3). Sevelamer has also been shown to reduce the absorption of several vitamins including folic acid (see sections 4.4 and 5.3). The potential risk to humans is unknown. Sevelamer carbonate should only be given to pregnant women if clearly needed and after a careful risk/benefit analysis has been conducted for both the mother and the foetus.</p><p><u>Breast-feeding</u></p><p>It is unknown whether Sevelamer/metabolites are excreted in human milk. The non-absorbed nature of Sevelamer indicates that excretion of Sevelamer in breast milk is unlikely. A decision on whether to continue/discontinue breastfeeding or to continue/discontinue therapy with Sevelamer carbonate should be made taking into account the benefit of breast-feeding to the child and the benefit of Sevelamer carbonate therapy to the woman.</p><p><!--[if gte vml 1]><v:shape
 id="_x0000_s1026" style='position:absolute;left:0;text-align:left;
 margin-left:77.85pt;margin-top:10.65pt;width:1.3pt;height:1pt;z-index:-251659776;
 mso-position-horizontal-relative:page;mso-position-vertical-relative:text'
 coordsize="26,20" o:allowincell="f" path="m,hhl26,e" filled="f"
 strokeweight=".85pt">
 <v:path arrowok="t"/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="4" height="2" src="file:///C:/Users/USER/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" /><u>Fertility</u></p><p>There are no data from the effect of Sevelamer on fertility in humans. Studies in animals have shown that Sevelamer did not impair fertility in male or female rats at exposures at a human</p><p>equivalent dose 2 times the maximum clinical trial dose of 13 g/day, based on a comparison of relative BSA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sevelamer has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile</u></p><p>The most frequently occurring (&ge; 5% of patients) adverse reactions were all in the gastrointestinal disorders system organ class. Most of these adverse reactions were mild to moderate in intensity.</p><p><u>Tabulated</u><u> list of adverse reactions</u></p><p>The safety of sevelamer (as either carbonate and hydrochloride salts) has been investigated in numerous clinical trials involving a total of 969 haemodialysis patients with treatment duration of 4 to 50 weeks (724 patients treated with sevelamer hydrochloride and 245 with sevelamer carbonate), 97 peritoneal dialysis patients with treatment duration of 12 weeks (all treated with sevelamer hydrochloride) and 128 patients with CKD not on dialysis with treatment duration of 8 to 12 weeks (79 patients treatment with sevelamer hydrochloride and 49 with sevelamer carbonate).</p><p>Adverse reactions that occurred during clinical trials or that were spontaneously reported from post-marketing experience are listed by frequency in the table below. The reporting rate is classified as very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to</p><p><!--[if gte vml 1]><v:shape id="_x0000_s1027" style='position:absolute;
 left:0;text-align:left;margin-left:297.6pt;margin-top:42.5pt;width:1pt;
 height:15.85pt;z-index:-251658752;mso-position-horizontal-relative:page;
 mso-position-vertical-relative:text' coordsize="20,317" o:allowincell="f"
 path="m,hhl,316e" filled="f" strokeweight=".58pt">
 <v:path arrowok="t"/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="2" height="23" src="file:///C:/Users/USER/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" />&lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), not known (cannot be estimated from the available data).</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><table border="1" cellspacing="1" cellpadding="1" style="width:680px"><tbody><tr><td style="text-align:center"><strong>Adverse reaction</strong></td><td style="width:355px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:center"><strong>Frequency of adverse reaction</strong></p></td></tr></tbody></table></td></tr><tr><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Hypersensitivity*</p></td></tr></tbody></table></td><td style="width:355px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very Rare</p></td></tr></tbody></table></td></tr><tr><td><table border="0" cellspacing="0" cellpadding="0" style="width:329px"><tbody><tr><td style="vertical-align:top; width:329px"><p>Nausea, vomiting, upper abdominal pain, Constipation</p></td></tr></tbody></table></td><td style="width:355px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Very Common</p></td></tr></tbody></table></td></tr><tr><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Diarrhoea, dyspepsia, flatulence, abdominal pain</p></td></tr></tbody></table></td><td style="width:355px">Common</td></tr><tr><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Intestinal obstruction, ileus/subileus, intestinal perforation</p></td></tr></tbody></table></td><td style="width:355px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Not known</p></td></tr></tbody></table></td></tr><tr><td><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Pruritus, rash</p></td></tr></tbody></table></td><td style="width:355px"><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Not known</p></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p><u>Paediatric population</u></p><p>In general, the safety profile for children and adolescents (6 to 18 years of age) is similar to the safety profile for adults.</p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia:</p><p>&nbsp;</p><table border="1" cellspacing="1" cellpadding="1" style="width:500px"><tbody><tr><td><p>-&nbsp; The National Pharmacovigilance Center (NPC):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;Call NPC at +966-11-2038222, Ext 2317-2356-2340</p><p>&middot;&nbsp; &nbsp; SFDA Call Center: 19999</p><p>&middot;&nbsp; &nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp; &nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sevelamer hydrochloride, which contains the same active moiety as Sevelamer carbonate, has been given to normal healthy volunteers in doses of up to 14 grams per day for eight days with no undesirable effects. In CKD patients, the maximum average daily dose studied was</p><p>14.4 grams of Sevelamer carbonate in a single daily dose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: All other therapeutic products, drugs for treatment of hyperkalemia and hyperphosphataemia. ATC code: V03AE02.</p><p><u>Mechanism</u><u> of action</u></p><p>Lamsev contains Sevelamer, a non-absorbed phosphate binding crosslinked polymer, free of metal and calcium. Sevelamer contains multiple amines separated by one carbon from the polymer backbone which become protonated in the stomach. These protonated amines bind negatively charged ions such as dietary phosphate in the intestine.</p><p><u>Pharmacodynamic</u><u> </u><u>effect</u></p><p>By binding phosphate in the gastrointestinal tract and decreasing absorption, Sevelamer lowers the phosphorus concentration in the serum. Regular monitoring of serum phosphorus levels is always necessary during phosphate binder administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacokinetic studies have not been carried out with Sevelamer carbonate. Sevelamer hydrochloride, which contains the same active moiety as Sevelamer carbonate, is not absorbed from the gastrointestinal tract, as confirmed by an absorption study in healthy volunteers.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data with Sevelamer reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity or genotoxicity.</p><p>Carcinogenicity studies with oral Sevelamer hydrochloride were conducted in mice (doses of up to 9 g/kg/day) and rats (0.3, 1, or 3 g/kg/day). There was an increased incidence of urinary bladder transitional cell papilloma in male rats of the high dose group (human equivalent dose twice the maximum clinical trial dose of 14.4 g).</p><p>There was no increased incidence of tumours observed in mice (human equivalent dose 3 times the maximum clinical trial dose).</p><p>In an in vitro mammalian cytogenetic test with metabolic activation, Sevelamer hydrochloride caused a statistically significant increase in the number of structural chromosome aberrations. Sevelamer hydrochloride was not mutagenic in the Ames bacterial mutation assay.</p><p>In rats and dogs, Sevelamer reduced absorption of fat soluble vitamins D, E and K (coagulation factors), and folic acid. Deficits in skeletal ossification were observed in several locations in foetuses of female rats dosed with Sevelamer at intermediate and high doses (human equivalent dose less than the maximum clinical trial dose of 14.4 g). The effects may be secondary to vitamin D depletion.</p><p>In pregnant rabbits given oral doses of Sevelamer hydrochloride by gavage during organogenesis, an increase of early resorptions occurred in the high-dose group (human equivalent dose twice the maximum clinical trial dose).</p><p>Sevelamer hydrochloride did not impair the fertility of male or female rats in a dietary administration study in which the females were treated from 14 days prior to mating through gestation and the males were treated for 28 days prior to mating. The highest dose in this study was 4.5 g/kg/day (human equivalent dose 2 times the maximum clinical trial dose of 13 g/day, based on a comparison of relative BSA).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mannitol, Crospovidone, Hydroxypropyl Cellulose, Colloidal silicon dioxide, Talc, Glyceryl Behenate, Aquarius TM&nbsp;Prime BBN119000 clear and Opacode Black S-1- 17823.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months

Use within 6 months after first opening.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30oC.</p><p>Keep the bottle container tightly closed in order to protect from moisture. Keep this medicine out of the sight and reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>180&rsquo;s HDPE Container.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Manufacturer:
Unit VII, SEZ, TSIIC, Plot No. SI,
Survey No’s: 411/P, 425/P, 434/P, 435/P & 458/P, Green Industrial Park, Polepally village,
Jedcherla Mandal, Mahaboobnagar District, Telangana, India.

Marketing Authorization Holder:
 Aurobindo Pharma Saudi Arabia Limited,
 Jeddah, Saudi Arabia.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>